Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 144
News
News | 22 June 2022

AstraZeneca and Merck announces results from phase 3 PROpel trial of Lynparza

LYNPARZA is approved in the U.S. for patients with HRR gene-mutated mCRPC (BRCA-mutated and other HRR gene mutations)

News
News | 22 June 2022

MedC Biopharma partners with A2W Pharma to develop cannabinoid therapeutics

Bringing next-gen cannabinoid therapeutics to cancer patients

News
News | 22 June 2022

Sadhana Nitro Chem commences production of its 1st para aminophenol plant

The company is now introducing the product into the India pharmaceutical market.

News
News | 22 June 2022

Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections

COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.

News
News | 21 June 2022

Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications

It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.

News
News | 21 June 2022

Cadila Pharma launches formulation development lab

The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab

News
News | 21 June 2022

Medix Biochemica acquires Bioresource Technology

Bioresource Technology's state of the art manufacturing facility in Weston, Florida

News
News | 21 June 2022

India welcomes TRIPS waiver deal at WTO

TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic

News
News | 20 June 2022

Unilever, Genomatica form venture to develop palm oil based alternatives

With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology

News
News | 20 June 2022

Cipla signs agreement for acquisition of 21.05% stake in Achira Labs

This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies

News
News | 20 June 2022

Aurobindo Pharma board approves acquisition of GLS Pharma

The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.

News
News | 20 June 2022

Polio Sub-National Immunization Day to be conducted from 19th June 2022

The states where Polio vaccine drops will be conducted includes: Bihar, Chandigarh, Delhi, Gujarat, Haryana, Jharkhand, Maharashtra, Punjab, Rajasthan, Uttarakhand, and West Bengal

News
News | 18 June 2022

Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%

Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21

News
News | 18 June 2022

Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation

Both manufacturing facilities are based out of Benguluru, India

News
News | 17 June 2022

Revelation Pharma completes 8th acquisition

Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.

News
News | 17 June 2022

Saint-Gobain Life Sciences expands manufacturing facility in Japan

The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry

News
News | 16 June 2022

Enko advances Enkompass platform through DNA-encoded library technology

Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions

News
News | 16 June 2022

Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India

Glenmark is the first company in India to market the innovative FDC of Indacaterol

News
News | 16 June 2022

LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA

With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development

News
News | 15 June 2022

Dr. Reddy's Lab launches sorafenib tablets in US

Dr. Reddy's Sorafenib Tablets, USP, are available in 200 mg tablets in bottle count sizes of 120.

Startup

Digitization